专利信息

首页 1 尾页共 10 条记录, 当前第1/1页。

专利标题：Pharmaceutical compositions

The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

专利标题：Purin derivatives for use in the treatment of fab-related diseases

ABSTRACT - 591008 The disclosure relates to the use of a DPP-4 inhibitor such as 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine which is represented by either of the formulae (I) (II) (III) or (IV) and pharmaceutically acceptable salt wherein the variables are as defined in the specification. These compounds are suitable for wound healing preferably in diabetic patients or for reducing destructive wound inflammation such as e.g. for reducing...

专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin

专利标题：Pharmaceutical compositions

专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin

专利标题：Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity

Angiotensin II receptor antagonist is used to prepare a medicament for treating people for whom type 2 diabetes has been diagnosed or prediabetes is suspected for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure. An independent claim is also included for a composition comprising telmisartan in combination with amlodipine or nifedipine; eplerenone or spironolactone; simvastatin or atorvastatin; rosiglitazone pioglitazone repaglin...

当前查询条件: [专利权人] 包含 'Boehringer Ingelheim International Gmbh' AND [药品] 包含 'Pioglitazone'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US20140079781A1	2014/3/20	US14/087388	2013/11/22
专利标题：Pharmaceutical compositions 专利权人：Boehringer Ingelheim International Gmbh; The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

2. NZ591008A	2013/6/28	NZ20090591008	2009/8/13
专利标题：Purin derivatives for use in the treatment of fab-related diseases 专利权人：Boehringer Ingelheim International Gmbh; ABSTRACT - 591008 The disclosure relates to the use of a DPP-4 inhibitor such as 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine which is represented by either of the formulae (I) (II) (III) or (IV) and pharmaceutically acceptable salt wherein the variables are as defined in the specification. These compounds are suitable for wound healing preferably in diabetic patients or for reducing destructive wound inflammation such as e.g. for reducing...

3. KR20130069615A	2013/6/26	KR20127028888	2011/5/4
专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin 专利权人：Boehringer Ingelheim International Gmbh;

4. EP2566464A1	2013/3/13	EP20110720070	2011/5/4
专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin 专利权人：Boehringer Ingelheim International Gmbh;

5. CN102883711A	2013/1/16	CN2011822242	2011/5/4
专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin 专利权人：Boehringer Ingelheim International Gmbh;

6. AU2011249771A1	2012/11/1	AU20110249771	2011/5/4
专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin 专利权人：Boehringer Ingelheim International Gmbh; The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

7. US20120107398A1	2012/5/3	US13/100328	2011/5/4
专利标题：Pharmaceutical compositions 专利权人：Boehringer Ingelheim International Gmbh; The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

8. TW201206917A	2012/2/16	TW20110115645	2011/5/4
专利标题：Pharmaceutical compositions 专利权人：Boehringer Ingelheim International Gmbh; The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

9. CA2795105A1	2011/11/10	CA20112795105	2011/5/4
专利标题：Pharmaceutical formulations comprising pioglitazone and linagliptin 专利权人：Boehringer Ingelheim International Gmbh; The present invention relates to pharmaceutical compositions comprising fixed dose combinations of a DPP-4 inhibitor drug and pioglitazone processes for the preparation thereof and their use to treat certain diseases.

10. EP1651213B1	2009/9/23	EP20040763484	2004/7/24
专利标题：Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity 专利权人：Boehringer Ingelheim International Gmbh; Angiotensin II receptor antagonist is used to prepare a medicament for treating people for whom type 2 diabetes has been diagnosed or prediabetes is suspected for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure. An independent claim is also included for a composition comprising telmisartan in combination with amlodipine or nifedipine; eplerenone or spironolactone; simvastatin or atorvastatin; rosiglitazone pioglitazone repaglin...

下载范围

下载内容